Home  >  Products  >  DMTF1 (cyclin D binding myb-like transcription factor 1) Blocking Peptide (the middle region of protein) (100ug)
DMTF1 (cyclin D binding myb-like transcription factor 1) Blocking Peptide (the middle region of protein) (100ug)

DMTF1 (cyclin D binding myb-like transcription factor 1) Blocking Peptide (the middle region of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-DMTF1 antibody (Catalogue #: ARP34828_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP34828
Size: 100 ug
Weight: 84kDa
Gene: 9988
Format: Lyophilized powder
Target: DMTF1 is a transcription factor that contains a cyclin D-binding domain, three central Myb-like repeats, and two flanking acidic transactivation domains at the N- and C-termini. DMTF1 is induced by the oncogenic Ras signaling pathway and functions as a tumor suppressor by activating the transcription of ARF and thus the ARF-p53 pathway to arrest cell growth or induce apoptosis. It also activates the transcription of aminopeptidase N and may play a role in hematopoietic cell differentiation. The transcriptional activity of DMTF1 is regulated by binding of D-cyclins. The gene encoding DMTF1 is hemizygously deleted in approximately 40% of human non-small-cell lung cancer and is a potential prognostic and gene-therapy target for non-small-cell lung cancer.
Alternative names: DMP1; DMTF; FLJ41265; hDMP1
See Full Product Listings >